1 – 10 of 24
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
The association between non-motor symptoms and cost in Parkinson’s disease
- Contribution to journal › Article
-
Mark
Conversion between NMSS and MDS-NMS in Parkinson's Disease
- Contribution to journal › Article
-
Mark
Effects of a Four-Strain Probiotic on Gut Microbiota, Inflammation, and Symptoms in Parkinson's Disease : A Randomized Clinical Trial
- Contribution to journal › Article
- 2024
-
Mark
Non-Motor Symptom Management : Insights into Adherence to Treatment Guidelines in Parkinson’s Disease Patients
- Contribution to journal › Article
- 2023
-
Mark
Neurofilament light predicts worse nonmotor symptoms and depression in Parkinson's disease
- Contribution to journal › Article
- 2022
-
Mark
Caregiver Burden in Late-Stage Parkinsonism and Its Associations
- Contribution to journal › Article
-
Mark
Opicapone versus placebo in the treatment of Parkinson’s disease patients with end-of-dose motor fluctuation-associated pain : rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial
- Contribution to journal › Article
- 2021
-
Mark
Effects of safinamide on pain in patients with fluctuating Parkinson's disease
- Contribution to journal › Article
-
Mark
Dopaminergic and serotonergic alterations in plasma in three groups of dystonia patients
- Contribution to journal › Article
-
Mark
Personalised advanced therapies in parkinson’s disease : The role of non-motor symptoms profile
- Contribution to journal › Article
